Neoadjuvant lenvatinib in a patient with invasive poorly differentiated thyroid cancer
{{output}}
Background: A limited number of case reports have investigated the role of tyrosine kinase inhibitors as neoadjuvant therapy in locally invasive poorly differentiated thyroid cancer (PDTC). ... ...